Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribonucleic acid synthesis, also known as transcription, is the cellular process by which RNA molecules are generated from a DNA template. This process is catalyzed primarily by the enzyme RNA polymerase in cells, and by viral RNA-dependent RNA polymerases in many viruses. The resulting RNAs serve various functions, including coding for proteins (mRNA), structural roles (rRNA), and regulatory or catalytic activities (tRNA, snRNA, etc.). Ribavirin targets ribonucleic acid synthesis through several mechanisms, including direct polymerase inhibition, mutagenesis, IMPDH inhibition, and disruption of capping enzymes. These effects are particularly relevant against many pathogenic viruses, including hepatitis C virus.
Direct inhibition of viral mRNA polymerases, Mutagenesis via incorporation into viral RNA, Inhibition of inosine monophosphate dehydrogenase (IMPDH), Disruption of viral mRNA capping
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribonucleic Acid Synthesis.